222 results on '"Gwak, Geum-Youn"'
Search Results
2. Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score
3. Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
4. Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
5. Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
6. Reply
7. Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
8. Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
9. Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study
10. Letter: comment on Park et al – the association of non‐alcoholic fatty liver disease between parents and adolescent children – authors' reply
11. Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
12. Letter: hereditary role in non‐alcoholic fatty liver disease – authors' reply
13. The association of non‐alcoholic fatty liver disease between parents and adolescent children
14. Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
15. Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea
16. Lysophosphatidylcholine
17. Proteome Multimarker Panel for the Early Detection of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and Comparison
18. Reply
19. Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development
20. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study
21. Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
22. Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
23. Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate
24. Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study
25. Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
26. Clinical Outcomes of Hepatitis B Virus–Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
27. Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B
28. Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study
29. Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure
30. The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study
31. Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
32. Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
33. Inclusive Quantification Assay of Serum Des‐γ‐Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry
34. Lysophosphatidylcholine
35. Author Correction: Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study
36. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease
37. Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea
38. Lysophosphatidylcholine
39. A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients
40. Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal
41. Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
42. Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea
43. Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study
44. Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
45. Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
46. Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase
47. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
48. Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
49. Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study
50. Long‐term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients—Functional cure unlikely
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.